Evidence map›Paper›PMID 41394667›Full record

ArticlebioRxiv : the preprint server for biology2026

Nuclear activities and interactome of the NS5 protein of Tick-Borne Encephalitis Virus.

Maxime Chazal, Aïssatou Aïcha Sow, Elodie Le Seac'h, Dana Hawasheen, Margarida Bonifacio, Mikael Feracci, Ségolène Gracias, Adrià Sogues, Melissa Molho, Heng Pan and 8 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Maxime ChazalUnité Signalisation Antivirale, UMR CNRS 3569, Université Paris Cité, Institut Pasteur, Paris, France.ORCID 0000-0002-3144-5032
Aïssatou Aïcha SowUnité Signalisation Antivirale, UMR CNRS 3569, Université Paris Cité, Institut Pasteur, Paris, France.ORCID 0000-0002-0500-2625
Elodie Le Seac'hUnité Signalisation Antivirale, UMR CNRS 3569, Université Paris Cité, Institut Pasteur, Paris, France.
Dana HawasheenUnité Signalisation Antivirale, UMR CNRS 3569, Université Paris Cité, Institut Pasteur, Paris, France.ORCID 0000-0001-7829-5484
Margarida BonifacioUnité Signalisation Antivirale, UMR CNRS 3569, Université Paris Cité, Institut Pasteur, Paris, France.ORCID 0009-0006-7704-0010
Mikael FeracciAix Marseille Université, AFMB, UMR CNRS 7257, Marseille, France.ORCID 0000-0001-5636-8208
Ségolène GraciasUnité Signalisation Antivirale, UMR CNRS 3569, Université Paris Cité, Institut Pasteur, Paris, France.ORCID 0009-0005-0040-9142
Adrià SoguesBacterial Cell Cycle Mechanisms Unit, UMR CNRS 3528, Université Paris Cité, Institut Pasteur Paris, France.ORCID 0000-0002-5752-6009
Melissa MolhoDepartment of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, USA.ORCID 0000-0002-9021-4920
Heng PanDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, USA.
Boris BonaventureDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, USA.ORCID 0000-0003-1473-7233
Jean-Pierre QuivyInstitut Curie, PSL Research University, Sorbonne Université, UMR CNRS 3664, Laboratoire Dynamique du Noyau, Equipe Labellisée Ligue contre le Cancer, Paris, France.ORCID 0000-0001-6557-7204
Geneviève AlmouzniInstitut Curie, PSL Research University, Sorbonne Université, UMR CNRS 3664, Laboratoire Dynamique du Noyau, Equipe Labellisée Ligue contre le Cancer, Paris, France.ORCID 0000-0001-5570-0723
Etienne DecrolyAix Marseille Université, AFMB, UMR CNRS 7257, Marseille, France.ORCID 0000-0002-6046-024X
Holly RamageDepartment of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, USA.ORCID 0000-0002-0390-6786
Jeffrey R JohnsonDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, USA.ORCID 0000-0002-4221-298X
Vincent CavalUnité Signalisation Antivirale, UMR CNRS 3569, Université Paris Cité, Institut Pasteur, Paris, France.ORCID 0000-0002-5458-6081
Nolwenn JouvenetUnité Signalisation Antivirale, UMR CNRS 3569, Université Paris Cité, Institut Pasteur, Paris, France.ORCID 0000-0001-6103-6048

Funding

Unraveling yellow fever 17D vaccine attenuation: The role of type I interferon and innate immunityR01AI124690 · NIAID · ROCKEFELLER UNIVERSITY · PI Charles M Rice · 2016 to 2026
$8.3M
Defining the Role of West Nile Virus-Host Protein Interactions in Evading Antiviral ImmunityR01AI143850 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI RAMAGE, HOLLY · 2019 to 2023
$2.2M
NIAID NIH HHS R01 AI124690NIAID NIH HHS R01 AI143850
6 · The paper itself

Abstract

Orthoflaviviruses are RNA viruses responsible for significant diseases in humans, domesticated animals and wildlife. Their NS5 protein is central in viral replication, functioning both as an RNA-dependent RNA polymerase and a methyltransferase, while also modulating cellular processes, including the interferon response. Although viral replication is cytoplasmic, the NS5 protein of several mosquito-borne orthoflaviviruses cycles between the cytoplasm and the nucleus of infected human cells. However, the nuclear localization and function of NS5 of tick-borne orthoflaviviruses, such as tick-borne encephalitis virus (TBEV), remained poorly understood. Microscopy analysis and cell fractionation revealed that the NS5 protein of TBEV localized to both the cytoplasm and nucleoplasm of infected cells. Mutagenesis studies identified critical residues required for its nuclear targeting. Mutating these residues in a TBEV replicon abolished viral replication. Immunoprecipitation-mass spectrometry analyses performed in two human cell lines infected with TBEV recovered 352 NS5 partners. Among them, 187 were nuclear or partially nuclear. By integrating our interactome data with that of Powassan virus (POWV), another tick-borne orthoflavivirus, we refined a list of 20 high-confidence NS5 partners, including splicing factors and chromatin modulators. Functional analysis revealed that seven of these nuclear partners significantly modulated viral replication, further underscoring the importance of nuclear NS5 in the viral life cycle. Our work advances our understanding of the nuclear function of the NS5 proteins of tick-borne orthoflaviviruses.

Identifiers

PMID41394667
PMCPMC12697543

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.